S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
China July exports rise, with trade surplus at record-high
Dems push Biden climate, health priorities toward Senate OK
Venezuela, Colombia border areas hopeful as reopening looms
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
China July exports rise, with trade surplus at record-high
Dems push Biden climate, health priorities toward Senate OK
Venezuela, Colombia border areas hopeful as reopening looms
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
China July exports rise, with trade surplus at record-high
Dems push Biden climate, health priorities toward Senate OK
Venezuela, Colombia border areas hopeful as reopening looms
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
Buffett's firm reports $44B loss but its businesses thrive
Musk says Twitter deal could move ahead with 'bot' info
Dems' climate, energy, tax bill clears initial Senate hurdle
Demand for grocery delivery cools as food costs rise
China July exports rise, with trade surplus at record-high
Dems push Biden climate, health priorities toward Senate OK
Venezuela, Colombia border areas hopeful as reopening looms
NASDAQ:MDRX

Allscripts Healthcare Solutions (MDRX) Stock Forecast, Price & News

$17.53
+2.08 (+13.46%)
(As of 08/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$16.01
$17.56
50-Day Range
$14.26
$17.53
52-Week Range
$13.05
$23.25
Volume
3.12 million shs
Average Volume
1.06 million shs
Market Capitalization
$2.03 billion
P/E Ratio
40.77
Dividend Yield
N/A
Price Target
$21.40

Allscripts Healthcare Solutions MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
25.5% Upside
$22.00 Price Target
Short Interest
Healthy
9.75% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.62
Upright™ Environmental Score
News Sentiment
1.00mentions of Allscripts Healthcare Solutions in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$5.55 M Sold Last Quarter
Proj. Earnings Growth
-1.49%
From $0.67 to $0.66 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Medical Sector

262nd out of 1,283 stocks

Computer Integrated Systems Design Industry

9th out of 45 stocks

Allscripts Healthcare Solutions logo

About Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Allscripts Healthcare Solutions Trading Up 13.5 %

MDRX Stock traded up $2.08 during mid-day trading on Friday, hitting $17.53. 3,122,237 shares of the company were exchanged, compared to its average volume of 1,055,445. Allscripts Healthcare Solutions has a 12-month low of $13.05 and a 12-month high of $23.25. The firm has a market capitalization of $2.03 billion, a P/E ratio of 40.77, a PEG ratio of 1.41 and a beta of 1.02. The business has a fifty day simple moving average of $15.57 and a 200-day simple moving average of $18.82. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 0.28.

Allscripts Healthcare Solutions (NASDAQ:MDRX - Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The software maker reported $0.18 EPS for the quarter, topping the consensus estimate of $0.15 by $0.03. Allscripts Healthcare Solutions had a net margin of 5.90% and a return on equity of 10.24%. The firm had revenue of $150.90 million for the quarter, compared to analyst estimates of $148.58 million. During the same period in the prior year, the business posted $0.17 EPS. The business's revenue for the quarter was up 6.9% compared to the same quarter last year. On average, equities research analysts predict that Allscripts Healthcare Solutions will post 0.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. StockNews.com downgraded Allscripts Healthcare Solutions from a "buy" rating to a "hold" rating in a research report on Friday, May 13th. The Goldman Sachs Group initiated coverage on shares of Allscripts Healthcare Solutions in a report on Tuesday, July 12th. They issued a "neutral" rating and a $21.00 price objective for the company. Piper Sandler cut their price objective on shares of Allscripts Healthcare Solutions from $19.00 to $17.00 in a research report on Thursday, June 9th. Finally, TheStreet lowered shares of Allscripts Healthcare Solutions from a "b" rating to a "c" rating in a report on Friday, May 6th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $21.33.

Insider Transactions at Allscripts Healthcare Solutions

In related news, Director Paul Black sold 60,000 shares of the stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $16.58, for a total transaction of $994,800.00. Following the transaction, the director now owns 1,254,631 shares of the company's stock, valued at approximately $20,801,781.98. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Thomas Langan sold 51,537 shares of the company's stock in a transaction on Tuesday, May 10th. The stock was sold at an average price of $18.12, for a total transaction of $933,850.44. Following the sale, the insider now owns 139,912 shares of the company's stock, valued at $2,535,205.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul Black sold 60,000 shares of the stock in a transaction on Friday, June 10th. The shares were sold at an average price of $16.58, for a total value of $994,800.00. Following the completion of the sale, the director now owns 1,254,631 shares in the company, valued at $20,801,781.98. The disclosure for this sale can be found here. Insiders sold a total of 318,015 shares of company stock worth $5,550,054 over the last ninety days. Company insiders own 2.29% of the company's stock.

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Stock News Headlines

AllScripts: Q2 Earnings Snapshot
Allscripts Announces Second Quarter of 2022 Results
Analyst Ratings for Allscripts Healthcare
Allscripts Healthcare Solutions Inc. Q1 Income Climbs
See More Headlines

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Company Calendar

Last Earnings
8/04/2022
Today
8/07/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Sector
Medical
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,000
Year Founded
1986

Price Target and Rating

Average Stock Price Forecast
$22.00
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+22.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
5 Analysts

Profitability

Net Income
$134.44 million
Pretax Margin
12.56%

Debt

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$2.76 per share
Book Value
$11.49 per share

Miscellaneous

Free Float
113,363,000
Market Cap
$2.03 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Mr. Richard J. Poulton (Age 57)
    CEO & Director
    Comp: $2.45M
  • Ms. Tejal Vakharia (Age 49)
    Sr. VP of Marketing & Gov. Affairs, Gen. Counsel and Chief Compliance Counsel
    Comp: $1.04M
  • Mr. Thomas J. Langan (Age 56)
    Pres & CCO
  • Ms. Leah Jones (Age 50)
    Chief Financial Officer
  • Mr. Joseph R. Rostock (Age 59)
    Sr. VP of Devel. & CTO
  • Jenny Gelinas
    VP of Investor Relations
  • Mr. Richard Elmore
    Sr. VP of Corp. Devel. & Strategy
  • Ms. Rebecca Whaley
    VP of Marketing
  • Ms. Lisa Hammond C.P.C. (Age 50)
    Sr. VP & Chief HR Officer
  • Mr. Paul Lewis
    Sr. VP of Sales & Services and Acting Gen. Mang.













MDRX Stock - Frequently Asked Questions

Should I buy or sell Allscripts Healthcare Solutions stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Allscripts Healthcare Solutions stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View analyst ratings for Allscripts Healthcare Solutions
or view top-rated stocks.

What is Allscripts Healthcare Solutions' stock price forecast for 2022?

5 Wall Street analysts have issued 12-month target prices for Allscripts Healthcare Solutions' shares. Their MDRX stock forecasts range from $17.00 to $26.00. On average, they expect Allscripts Healthcare Solutions' share price to reach $22.00 in the next year. This suggests a possible upside of 25.5% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions
or view top-rated stocks among Wall Street analysts.

How has Allscripts Healthcare Solutions' stock price performed in 2022?

Allscripts Healthcare Solutions' stock was trading at $18.45 at the start of the year. Since then, MDRX shares have decreased by 5.0% and is now trading at $17.53.
View the best growth stocks for 2022 here
.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our earnings forecast for Allscripts Healthcare Solutions
.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) issued its earnings results on Thursday, August, 4th. The software maker reported $0.18 EPS for the quarter, beating the consensus estimate of $0.15 by $0.03. The software maker earned $150.90 million during the quarter, compared to analysts' expectations of $148.58 million. Allscripts Healthcare Solutions had a net margin of 5.90% and a trailing twelve-month return on equity of 10.24%. The firm's revenue was up 6.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.17 earnings per share.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its Board of Directors has initiated a stock repurchase plan on Wednesday, May 26th 2021, which authorizes the company to repurchase $350,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 14% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.52 billion-$1.53 billion, compared to the consensus revenue estimate of $1.53 billion.

What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include Loomis Sayles & Co. L P (1.32%), Fort Washington Investment Advisors Inc. OH (0.69%), Smith Graham & Co. Investment Advisors LP (0.48%), SG Americas Securities LLC (0.32%), Cambria Investment Management L.P. (0.19%) and New York State Teachers Retirement System (0.19%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends for Allscripts Healthcare Solutions
.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $17.53.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $2.03 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

Allscripts Healthcare Solutions employs 8,000 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.
Read More

When was Allscripts Healthcare Solutions founded?

Allscripts Healthcare Solutions was founded in 1986.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for Allscripts Healthcare Solutions is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.

This page (NASDAQ:MDRX) was last updated on 8/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.